Immunogen
Synthetic peptide from human protein at AA range: 61-110
Specificity
The antibody detects endogenous Abin-2
Formulation
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Dilution rate
IHC-p 1:50-200, ELISA 1:10000-20000. IF 1:50-200
Purification process (Immunogen)
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Background
This gene encodes a protein which acts as an inhibitor of NFkappaB activation. The encoded protein is also involved in MAP/ERK signaling pathway in specific cell types. It may be involved in apoptosis of endothelial cells. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on the X chromosome.[provided by RefSeq, May 2014],
Function
function:Inhibits NF-kappa-B activation by blocking the interaction of RIPK1 with its downstream effector IKBKG. Forms a ternary complex with NFKB1 and MAP3K8 but appears to function upstream of MAP3K8 in the TLR4 signaling pathway that regulates MAP3K8 activation.,subunit:Interacts with STK11, TNFAIP3, IKBKG, NFKB1, MAP3K8 and RIPK1.,tissue specificity:Ubiquitously expressed in all tissues examined.,
Gene Name
TNIP2 ABIN2 FLIP1
Protein name
TNFAIP3-interacting protein 2 (A20-binding inhibitor of NF-kappa-B activation 2) (ABIN-2) (Fetal liver LKB1-interacting protein)
Other name
TNFAIP3-interacting protein 2 (A20-binding inhibitor of NF-kappa-B activation 2;ABIN-2;Fetal liver LKB1-interacting protein)
Human protein sequence Database
Q8NFZ5
Mouse protein sequence database
Q99JG7
Rat protein sequence database
Cellular localization
Cytoplasm . Nucleus .
Tissue expression
Ubiquitously expressed in all tissues examined.